Please ensure Javascript is enabled for purposes of website accessibility
ホーム > 製品 > 抗体 > バイオシミラー

Anti-Human CD19 & PD-L1 & 4-1BB/TNFRSF9/CD137 & CD3 epsilon Multispecific Reference Antibody (Emfizatamab, RUO) (HB996096)

Anti-Human CD19 & PD-L1 & 4-1BB/TNFRSF9/CD137 & CD3 epsilon Multispecific Reference Antibody (Emfizatamab, RUO)
Anti-Human CD19 & PD-L1 & 4-1BB/TNFRSF9/CD137 & CD3 epsilon Multispecific Reference Antibody (Emfizatamab, RUO)
Anti-Human CD19 & PD-L1 & 4-1BB/TNFRSF9/CD137 & CD3 epsilon Multispecific Reference Antibody (Emfizatamab, RUO)
Anti-Human CD19 & PD-L1 & 4-1BB/TNFRSF9/CD137 & CD3 epsilon Multispecific Reference Antibody (Emfizatamab, RUO)
Anti-Human CD19 & PD-L1 & 4-1BB/TNFRSF9/CD137 & CD3 epsilon Multispecific Reference Antibody (Emfizatamab, RUO)
Anti-Human CD19 & PD-L1 & 4-1BB/TNFRSF9/CD137 & CD3 epsilon Multispecific Reference Antibody (Emfizatamab, RUO)
価格(USD):
スペック:
  • 100ug
  • 1mg
  • 5mg
  • 10mg
  • 25mg
  • 50mg
  • 100mg
数量:
お問い合わせ
  • 概要

  • イメージ

  • 参考文献

  • データシート

  • SDS

概要
カタログ番号HB996096
説明
Emfizatamab (HB996096) is a research-grade recombinant antibody targeting CD19. Produced in mammalian cells with native-like glycosylation.
Highlights
  • ●Research Grade — For PK/PD studies, assay development, and ADA research.
  • ●Native Glycosylation — Mammalian expression ensures native-like patterns.
種反応性Human
アプリケーションELISA, Bioactivity: FCM, Functional assay, Research in vivo, WB
クローン性Monoclonal
アイソタイプ(scFv-kappa-heavy)-G1_L-kappa-(scFv-heavy-kappa)-(scFv-heavy-kappa)
テスト済みアプリケーション WB
ターゲット B-lymphocyte antigen CD19, B-lymphocyte surface antigen B4, CD19, Differentiation antigen CD19, T-cell surface antigen Leu-12, CD152, CTLA-4, CTLA4, Cytotoxic T-lymphocyte protein 4, Cytotoxic T-lymphocyte-associated antigen 4, 4-1BB ligand receptor, CD137, CDw137, ILA, T-cell antigen 4-1BB homolog, T-cell antigen ILA, TNFRSF9, Tumor necrosis factor receptor superfamily member 9, CD3E, CD3e, T-cell surface antigen T3/Leu-4 epsilon chain, T-cell surface glycoprotein CD3 epsilon chain, T3E
エンドトキシンレベル < 10 EU/mg
純度 >95% as determined by SDS-PAGE.
精製 Protein A/G purified from cell culture supernatant.
アクセッション番号 P15391 & Q9NZQ7 & Q07011 & P07766
形態 Liquid
保存バッファー 0.01M PBS pH 7.4.

データシートのハードコピーまたはロット固有のCOAに記載された具体的なバッファー情報を参照してください。

製品使用情報
アプリケーション 希釈
WB 1:500-1:2000
安定性と保存 Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
別名GNC038, GNC-038, GNC038, 2559704-23-1
背景Emfizatamab is an anti-CD19/CD3E/TNFRSF9/PD-L1 monoclonal antibody.
注意事項 For research use only. Not suitable for clinical or therapeutic use.
Isotype Control Human IgG1 Recombinant Isotype Control Antibody (13R4) (HV080507)
イメージ
  • Anti-Human CD19 & PD-L1 & 4-1BB/TNFRSF9/CD137 & CD3 epsilon Multispecific Reference Antibody (Emfizatamab, RUO)

    SDS-PAGE

    SDS-PAGE for Research Grade Emfizatamab.

  • Anti-Human CD19 & PD-L1 & 4-1BB/TNFRSF9/CD137 & CD3 epsilon Multispecific Reference Antibody (Emfizatamab, RUO)

    Bioactivity

    Detects recombinant CD137 (Catalog No: HC336011) in indirect ELISA.

  • Anti-Human CD19 & PD-L1 & 4-1BB/TNFRSF9/CD137 & CD3 epsilon Multispecific Reference Antibody (Emfizatamab, RUO)

    Western blot

    Western blot analysis was performed using anti-CD3E monoclonal antibody at 1ug/mL on various samples.
    Lane 1: recombinant human CD3E (Catalog No: HY057021)

参考文献
Formula
Mass (g) = Concentration (mol/L) × Volume (L) × MW (g/mol)
Enter any 2 of Mass, Concentration, Volume + Molecular Weight to solve for the unknown.
Mass
=
Concentration
×
Volume
Molecular Weight *
g/mol
Formula
C₁ × V₁ = C₂ × V₂
Enter any 3 of the 4 values to solve for the unknown.
Stock Solution
C₁ (Stock Conc.)
×
V₁ (Stock Vol.)
=
Working Solution
C₂ (Working Conc.)
×
V₂ (Working Vol.)
レコメンデーション

お問い合わせ カスタムクォート、大量リクエストおよびその他の問題については

メール: [email protected]

ディストリビューターリスト